morning welcome quest diagnostics fourth quarter first quarter conference call operator instruction entire content call include presentation question answer session follow copyright property quest diagnostics right reserve redistribution retransmission rebroadcast call form without write consent quest diagnostics strictly like introduce vice president investor investor relation quest diagnostics ahead please vice president investor relation thank good morning chairman chief executive officer president mark chief financial officer call make forward look statement measure provide reconciliation measure comparable measure table earn press release actual result differ materially project risk uncertainty include impact pandemic affect quest diagnostics future result include limit describe recent annual report form subsequently file quarterly report form current report form company continue believe impact pandemic future operate result cash flow financial condition primarily drive pandemic severity duration healthcare insurer government client payer reimbursement rate molecular test pandemic impact healthcare system economy time scope effectiveness federal state local governmental response pandemic driver beyond company knowledge control call reference report refer report dilute reference adjust refer adjust dilute reference base test volume base business refer test volume exclude test growth rate associate long term outlook projection include total revenue growth revenue growth acquisition organic revenue growth adjust earn growth compound annual growth rate finally revenue growth rate acquisition measure base business chairman chief executive officer thank everyone join today quest strong first quarter base business continue recover near pandemic level contribution acquisition relationship accelerate growth base business help offset reduction demand test line industry trend march first time since pandemic begin monthly organic revenue base business grow versus baseline note recent investor quest position grow exit pandemic people return normal activity address routine care issue request past year also press release morning board director increase company share repurchase authorization billion second time year expect launch accelerate share repurchase amount billion come morning performance first quarter provide perspective industry dynamic update base business mark provide detail financial result detail quarter want share perspective ongoing role test year pandemic provide think recent news regard test remain critical supply vaccine continue available test help control spread virus addition reduce hospitalization save life continue test help segment economy reopen become vaccinate vaccination front center mind people test remain critical element safely return life also like share perspective recent development regard occur count recently report explore alternative collection effort burdensome laboratory alternative mention survey representative sample independent hospital physician office laboratory instead report laboratory submit data year stop data collection process long follow extensive progress indecipherable hospital outreach physician office report higher fatal rate test independent represent first round data report agree count independent analysis indecipherable also provide evidence clinical schedule would higher representative sample include data hospital physician office department indecipherable collect hospital outpatient physician office would impact rate test believe accurate reliable test remain critical part nation ongoing response pandemic also million senior require routine screen care past year need avoid next round indecipherable help ensure senior continue access critical service need rely additionally recent report indecipherable challenge work indecipherable determine next step respect litigation continue work policymakers establish critical schedule truly representative whole market support continue innovation access vital laboratory service congress originally intend turn result first quarter total revenue grow billion earn share increase report basis nearly adjust basis cash provide operation nearly triple million mention earlier first quarter base business perform highest level since start pandemic continue recover throughout quarter demand test slow quarter reflect industrywide trend perform average molecular test first quarter current capacity approximately test engage several front bring immediate test school business industry like travel entertainment rely bring people back together safely large number current focus school quest position help extensive logistics network ability offer high quality effective classroom test want help back school work range partner quickly efficiently continue make progress point strategy accelerate growth drive operational excellence discuss strategy detail week investor talk today indecipherable highlight quarter excite agreement acquire outreach laboratory service business nation highly integrate multi state healthcare system indicate investor board discussion leader modern health system like outreach laboratory service business currently operate hospital clinical laboratory service provider patient track complete acquisition year professional laboratory service relationship health begin good start contribute revenue quarter recently announce sale minority share solution iqvia million iqvia strategic vision ability lead solution next phase journey global leader special service quest support strategic partner make good progress take advantage plan access first quarter unite healthcare implement initiative remove network benefit group selective state also broaden leakage redirection effort indecipherable eight state quarter benefit initiative finally renew long stand strategic relationship health provide comprehensive clinical laboratory service million member health affiliate unite care turn strategy drive operational excellence track deliver save across business process also improve customer experience quality quarter achieve year year improvement tier quality metric track gauge operational performance turn mark provide detail financial performance mark mark executive vice president chief financial first quarter consolidate revenue billion versus prior year revenue diagnostic information service grow approximately compare prior year reflect ongoing demand test service lesser extent continue recovery base test revenue increase versus prior year volume measure number requisition increase versus prior year acquisition contribute impact severe winter weather quarter negatively impact volume approximately compare first quarter baseline total base test volume increase benefit partnership begin exclude impact weather first quarter last year base test volume decline approximately first quarter versus baseline march represent store view recovery base business since pandemic begin test volume decline faster expect throughout decline coincide reduce demand across industry importantly volume stabilize last several week result approximately million molecular test nearly serology test contribute nearly volume growth versus prior year exit first quarter average approximately molecular test serology test revenue requisition increase versus prior year drive largely test modest unit price headwind line expectation report operate income first quarter million revenue compare million revenue last year adjust basis operate income million revenue compare million revenue last year year year increase operate margin drive strong revenue growth first quarter continue demand test ongoing recovery base business report quarter compare year adjust compare last year cash provide operation million first quarter versus million complete million share repurchase quarter approximately billion cash balance sheet include proceed divestiture currently billion cash available deployment follow billion increase share repurchase authority announce today ability execute approximately billion additional buyback year expect launch accelerate share repurchase transaction approximately billion come turn guidance update outlook first half follow revenue expect billion billion increase approximately versus prior year report expect range adjust range cash provide operation expect least billion capital expenditure expect approximately million conclude briefly review assumption embed update first half outlook consideration think remainder expect continue steady improvement base business throughout store view exclude base business remain slightly baseline second quarter continue anticipate full recovery base business compare baseline second half assume molecular test volume average roughly test meaningful change serology test volume compare give significant progress vaccination continue expect decline clinical demand molecular test second half versus expectation first half return life test school test program partially offset decline clinical demand later year continue believe strongly value serology test assume material increase demand serology test forward finally molecular reimbursement hold relatively steady first quarter currently expect trend continue public health emergency extend likely trend lower second half year molecular volume shift clinical diagnostic test return life surveillance test turn back chairman chief executive officer mark summarize strong start base business continue recover back near pandemic level people address routine care issue past year finally like thank quest employee continue serve need people rely quest every happy take question operator